Glycopyrronium Bromide and Neostigmine Metilsulfate 0.5mg/2.5mg per mL

New Zealand - English - Medsafe (Medicines Safety Authority)

Active ingredient:
Glycopyrronium bromide 0.5 mg/mL; Neostigmine metilsulfate 2.5 mg/mL
Available from:
Boucher & Muir (NZ) Ltd t/a Mercury Pharma (NZ)
INN (International Name):
Glycopyrronium bromide 0.5 mg/mL
Pharmaceutical form:
Solution for injection
Active: Glycopyrronium bromide 0.5 mg/mL Neostigmine metilsulfate 2.5 mg/mL Excipient: Citric acid Citric acid monohydrate Dibasic sodium phosphate dodecahydrate Sodium hydroxide Water for injection
Prescription type:
Manufactured by:
PCAS Finland Oy
Therapeutic indications:
Reversal of residual non-depolarising (competitive) neuromuscular block.
Product summary:
Package - Contents - Shelf Life: Ampoule, glass, Type I - 10 dose units - 24 months from date of manufacture stored at or below 25°C protect from light
Authorization number:
Authorization date:

Similar products

Search alerts related to this product

Share this information